Iveric Bio Inc reports results for the quarter ended in September - Earnings Summary

IVERIC bio

09/11/2021 12:38

* Iveric Bio Inc  ISEE.OQ  reported a quarterly adjusted loss
of 23 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 29 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Iveric Bio Inc's reported EPS for the quarter was a loss of 23
cents​.
* The mean earnings estimate of analysts had fallen by
about 4.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Iveric Bio Inc shares had risen by 12.7% this quarter and
gained 164.8% so far this year.
* The company reported a quarterly loss of $24.55 million.
* Wall Street's median 12-month price target for Iveric Bio Inc
is $21.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 12:38 p.m.
 ​All figures in US dollars unless otherwise stated